Antagonist affinity measurements at the Gi-coupled human histamine H3 receptor expressed in CHO cells

BMC Pharmacology

Volumn 8, Issue , 2008, Pages

  Baker, Jillian G ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

1 [2 (AMIDINOTHIO)ETHYL]GUANIDINE; 2 (2 PYRIDYL)ETHYLAMINE; 4 METHYLHISTAMINE; ALPHA METHYLHISTAMINE; AMTHAMINE; BETA ADRENERGIC RECEPTOR; BURIMAMIDE; CHLORPHENIRAMINE; CIMETIDINE; CLEMASTINE; CLOBENPROPIT; CYCLIC AMP; DIMAPRIT; G PROTEIN COUPLED RECEPTOR; HISTAMINE; HISTAMINE H3 RECEPTOR; HISTAMINE H3 RECEPTOR AGONIST; IMETIT; IMMEPIP; IMPENTAMINE; N METHYLHISTAMINE; PROXYFAN; RANITIDINE; RECEPTOR BLOCKING AGENT; RECEPTOR SUBTYPE; TELE METHYLHISTAMINE; THIOPERAMIDE; TRIPROLIDINE; UNINDEXED DRUG; VUF 5681; ANTIHISTAMINIC AGENT; INHIBITORY GUANINE NUCLEOTIDE BINDING PROTEIN;

ANIMAL CELL; ARTICLE; CHO CELL; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFICACY; DRUG RECEPTOR BINDING; GENETIC TRANSCRIPTION; IC 50; NONHUMAN; PROTEIN EXPRESSION; PROTEIN SYNTHESIS INHIBITION; REPORTER GENE; ANIMAL; BIOSYNTHESIS; COMPARATIVE STUDY; CRICETULUS; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; HAMSTER; HUMAN; PHYSIOLOGY;

ANIMALS; CHO CELLS; CRICETINAE; CRICETULUS; GENE EXPRESSION REGULATION; GTP-BINDING PROTEIN ALPHA SUBUNITS, GI-GO; HISTAMINE ANTAGONISTS; HUMANS; RECEPTORS, HISTAMINE H3;

EID: 45949088598     PISSN: None     EISSN: 14712210     Source Type: Journal    
DOI: 10.1186/1471-2210-8-9     Document Type: Article

References (47)

1. Arunlakshana O Schild HO Some quantitative uses of drug antagonists Br J Pharmacol Chemother 1959, 14(1):48-58. 1481829 13651579
2. Ash ASF Schild HO Receptors mediating some actions of histamine Br J Pharmacol Chemother 1966, 27:427-439. 1510832 4381779
3. Hill SJ G protein-coupled receptors: Past, present and future Br J Pharmacol 2006, 147:S27-S37. 1760739 16402114 10.1038/sj.bjp.0706455
4. Black JW Duncan WAM Shanks RG Comparison of some Properties of pronethalol and propranolol Br J Pharmacol 1965, 25:577-591.
5. Black JW Duncan WA Durant CJ Ganellin CR Parsons ME Definition and antagonism of histamine H2-receptors Nature 1972, 236:385-390. 10.1038/ 236385a0 4401751
6. Granneman JG The putative beta4-adrenergic receptor is a novel state of the beta1-adrenergic receptor Am J Physiol Endocrinol Metab 2001, 280:E199-202. 11158920
7. Molenaar P The 'state' of beta-adrenoceptors Br J Pharmacol 2003, 140:1-2. 1574015 12967928 10.1038/sj.bjp.0705420
8. Arch JR Do low-affinity states of beta-adrenoceptors have roles in physiology and medicine? Br J Pharmacol 2004, 143:517-518. 1575436 15514247 10.1038/sj.bjp.0705991
9. Pak MD Fishman PH Anomalous behaviour of CGP 12177A on beta 1-adrenergic receptors J Recept Signal Transduction Res 1996, 16:1-23. 10.3109/ 10799899609039938
10. Konkar AA Zhu Z Granneman JG Aryloxypropanolamine and catecholamine ligand interactions with the β1-adrenergic receptor: Evidence for interaction with distinct conformations of β1-adrenergic receptors J Pharmacol Exp Ther 2000, 294:923-932. 10945842
11. 1 -adrenoceptor in ferret ventricular myocardium Br J Pharmacol 2002, 135:451-461. 1573134 11815381 10.1038/sj.bjp.0704450
12. Baker JG Hall IP Hill SJ Agonist actions of "β-blockers" provide evidence for two agonist activation sites or conformations of the human β1-adrenoceptor Mol Pharmacol 2003, 63:1312-1321. 10.1124/ mol.63.6.1312 12761341
13. Baker JG Sites of action of β-ligands at the human β1-adrenoceptor J Pharmacol Exp Ther 2005, 313:1163-1171. 10.1124/ jpet.104.082875 15716385
14. Kaumann AJ Preitner F Sarsero D Molenaar P Revelli JP Giacobino JP (-)-CGP 12177 causes cardiostimulation and binds to cardiac putative beta 4-adrenoceptors in both wild-type and beta 3-adrenoceptor knockout mice Mol Pharmacol 1998, 53:670-675. 9547357
15. Kaumann AJ Engelhardt S Hein L Molenaar P Lohse M Abolition of (-)-CGP 12177-evoked cardiostimulation in double beta1/beta2-adrenoceptor knockout mice. Obligatory role of beta1-adrenoceptors for putative beta4-adrenoceptor pharmacology Naunyn Schmiedebergs Arch Pharmacol 2001, 363:87-93. 10.1007/s002100000336 11191841
16. Cussac D Newman-Tancredi A Duqueyroix D Pasteau V Millan MJ Differential activation of Gq/11 and Gi(3) proteins at 5-hydroxytryptamine(2C) receptors revealed by antibody capture assays: Influence of receptor reserve and relationship to agonist-directed trafficking Mol Pharmacol 2002, 62:578-589. 10.1124/mol.62.3.578 12181434
17. Cordeaux Y Ijzerman AP Hill SJ Coupling of the human A1 adenosine receptor to different heterotrimeric G proteins: Evidence for agonist-specific G protein activation Br J Pharmacol 2004, 143:705-714. 1575922 15302686 10.1038/sj.bjp.0705925
18. Baker JG Hill SJ A comparison of the antagonist affinities for the Gi and Gs-coupled states of the human adenosine A1 receptor J Pharmacol Exp Ther 2007, 320:218-228. 10.1124/jpet.106.113589 17018691
19. Baker JG Evidence for a secondary state of the human β3-adrenoceptor Mol Pharmacol 2005, 68:1645-1655. 16129733
20. Baker JG Hall IP Hill SJ Influence of agonist efficacy and receptor phosphorylation on antagonist affinity measurements: Differences between second messenger and reporter gene responses Mol Pharmacol 2003, 64:679-688. 10.1124/mol.64.3.679 12920204
21. Azzi M Charest PG Angers S Rosseau G Kohout T Bouvier M Pineryo G Beta-arrestin-mediated activation of MAPK by inverse agonists reveals distinct active conformations for G protein-coupled receptors Proc Natl Acad Sci USA 2003, 100:11406-11. 208770 13679574 10.1073/pnas.1936664100
22. Baker JG Hall IP Hill SJ Agonist and inverse agonist actions of "β-blockers" at the human β2-adrenoceptor provide evidence for agonist-directed signalling Mol Pharmacol 2003, 64:1357-1369. 10.1124/mol.64.6.1357 14645666
23. Wei H Ahn S Shenoy SK Karnik SS Hunyadi L Luttrell LM Lefkowitz RJ Independent β-arrestin 2 and G-protein-mediated pathways for angiotensin II activation of extracellular signal regulated kinase 1 and 2 Proc Natl Acad Sci USA 2003, 100:10782-10787. 196880 12949261 10.1073/ pnas.1834556100
24. Sato M Horinouchi T Hutchinson DS Evans BA Summers RJ Ligand-directed signaling at the beta3-adrenoceptor produced by 3-(2-Ethylphenoxy) -1-[(1,S)-1,2,3,4-tetrahydronapth-1-ylamino]-2S-2-propanol oxalate (SR59230A) relative to receptor agonists Mol Pharmacol 2007, 72:1359-1368. 10.1124/mol.107.035337 17717109
25. Baker JG A study of antagonist affinities for the human histamine H2 receptor British Journal of Pharmacology
26. Parsons ME Ganellin CR Histamine and its receptors Br J Pharmacol 2006, 147:S127-35. 1760721 16402096 10.1038/sj.bjp.0706440
27. Arrang JM Garbarg M Schwartz JC Auto-inhibition of brain histamine release mediated by a novel class (H3) of histamine receptor Nature 1983, 302:832-837. 10.1038/302832a0 6188956
28. Arrang J-M Garbarg M Lancelo J-C Lecomte J-M Pollard H Robba M Schunack W Schwartz J-C Highly potent and selective ligands for histamine H3-receptors Nature 1987, 327:117-123. 10.1038/327117a0 3033516
29. Lovenberg TW Roland BL Wilson SJ Jiang X Pyati J Huvar A Jackson MR Erlander MG Cloning and functional expression of the human histamine H3 receptor Mol Pharmacol 1999, 55:1101-1107. 10347254
30. Hill SJ Ganellin CR Timmerman H Schwartz JC Shankley NP Young JM Schunack W Levi R Haas HL International Union of Pharmacology. XIII. Classification of Histamine Receptors Pharmacol Rev 1997, 49:253-278. 9311023
31. Bongers G Bakker RA Leurs R Molecular aspects of the histamine H3 receptor Biochem Pharmacol 2007, 73:1195-1204. 10.1016/j.bcp.2007.01.008 17276412
32. Kenakin T Inverse, protean, and ligand-selective agonism: Matters of receptor conformation FASEB J 2001, 15:598-611. 10.1096/fj.00-0438rev 11259378
33. Gbahou F Rouleau A Morisset S Parmentier R Crochet S Lin JS Ligneau X Tardivel-Lacombe J Stark H Schunack W Ganellin CR Schwartz JC Arrang JM Protean agonism at histamine H3 receptors in vitro and in vivo Proc Natl Acad Sci USA 2003, 100:11086-11091. 196931 12960366 10.1073/ pnas.1932276100
34. Donaldson J Brown AM Hill SJ Influence of rolipram on the cyclic-3′,5′-adenosine monophosphate response to histamine and adenosine in slices of guinea-pig cerebral cortex Biochem Pharmacol 1988, 37:715-723. 10.1016/0006-2952(88)90146-3 2829922
35. Stephenson RP A modification of receptor theory Br J Pharmacol 1956, 11:5109-5116.
36. Qiu R Melmon KL Khan MM Effects of histamine-trifluoromethyl-toluidide derivative (HTMT) on intracellular calcium in human lymphocytes J Pharmacol Exp Ther 1990, 253:1245-52. 2359026
37. Martínez-Mir MI Estañ L Morales-Olivas FJ Rubio E Effect of histamine and histamine analogues on human isolated myometrial strips Br J Pharmacol 1992, 107:528-531. 1907891 1358393
38. Wieland K Bongers G Yamamoto Y Hashimoto T Yamatodani A Menge WM Timmerman H Lovenberg TW Leurs R Constitutive activity of histamine h(3) receptors stably expressed in SK-N-MC cells: Display of agonism and inverse agonism by H(3) antagonists J Pharmacol Exp Ther 2001, 299:908-14. 11714875
39. Baker JG Hill SJ Multiple GPCR conformations and signalling pathways: implications for antagonist affinity measurements Trends Pharmacol Sci 2007, 28:274-381. 10.1016/j.tips.2007.06.011
40. Zirihi GN Grellier P Guede-Guina F Bodo B Mambu L Isolation, characterization and antiplasmodial activity of steroidal alkaloids from Funtumia elastica (Preuss) Stapf Bioorg Med Chem Lett 2005, 15: 2637-2640. 10.1016/j.bmcl.2005.03.021 15863333
41. Cowart M Sun M Zhao C Witte DG Miller TR Krueger KM Browman K Fox GB Bennani YL Esbenshade TA Hancock AA A new family of histamine H-3 receptor antagonists based on a natural product: Discovery, SAR, and properties of the series Inflammation Research 2007, 56(Suppl 1):S47-S48. 10.1007/s00011-006-0523-9 17806176
42. Lim HD Smits RA Bakker RA van Dam CM de Esch IJ Leurs R Discovery of S-(2-guanidylethyl)-isothiourea (VUF 8430) as a potent nonimidazole histamine H4 receptor agonist J Med Chem 2006, 49:6650-6651. 10.1021/ jm060880d 17154494
43. Kitbunnadaj R Zuiderveld OP De Esch IJ Vollinga RC Bakker R Lutz M Spek AL Cavoy E Deltent MF Menge WM Timmerman H Leurs R Synthesis and structure-activity relationships of conformationally constrained histamine H(3) receptor agonists J Med Chem 2003, 46:5445-5457. 10.1021/ jm030905y 14640553
44. Kitbunnadaj R Zuiderveld OP Christophe B Hulscher S Menge WM Gelens E Snip E Bakker RA Celanire S Gillard M Talaga P Timmerman H Leurs R Identification of 4-(1H-imidazol-4(5)-ylmethyl)pyridine (immethridine) as a novel, potent, and highly selective histamine H(3) receptor agonist J Med Chem 2004, 47:2414-7. 10.1021/jm049932u 15115383
45. Moreno-Delgado D Torrent A Gomez-Ramirez J de Esch I Blanco I Ortiz J Constitutive activity of H-3 autoreceptors modulates histamine synthesis in rat brain through the cAMP/PKA pathway Neuropharmacology 2006, 51:517-523. 10.1016/j.neuropharm.2006.04.010 16769092
46. January B Seibold A Whaley B Hipkin RW Lin D Schonbrunn A Barber R Clark RB β2-adrenergic receptor desensitization, internalization and phosphorylation in response to full and partial agonists J Biol Chem 1997, 272:23871-23879. 10.1074/jbc.272.38.23871 9295336
47. Clark RB Knoll BJ Barber R Partial agonists and G-protein coupled receptor desensitization Trends Pharmacol Sci 1999, 20:279-286. 10.1016/ S0165-6147(99)01351-6 10390646